CI Cigna
Q1 2025 10-Q
Cigna (CI) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 2, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ1 2025 10-Q
Management Discussion & Analysis
- • No quarterly revenue or YoY comparison data disclosed in this section
- • No profitability or margin figures provided
Risk Factors
- • Debt securities portfolio carrying value decreased from $9.4B to $8.2B due to HCSC transaction; 84% investment grade unchanged since prior year
- • Commercial mortgage loan portfolio $1.3B, >75% non-office exposure; office sector weak but stabilizing for higher-quality assets, impacts investor appetite
Quarterly Financial SummaryXBRL
Revenue
$65.5B
▲ +14.4% YoY
Net Income
$1.3B
▲ +577.6% YoY
Operating Margin
3.0%
▼ -93bp YoY
Net Margin
2.0%
▲ +250bp YoY
EPS (Diluted)
$4.85
▲ +600.0% YoY
Operating Cash Flow
$1.9B
▼ -60.3% YoY
Source: XBRL data from Cigna Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Cigna Quarterly Reports
Get deeper insights on Cigna
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.